Stock Alert: Endo Int'l Rises 7%

(RTTNews) - Shares of Endo International plc (ENDP) are gaining 7% on Monday morning after the company said it will acquire BioSpecifics Technologies Corp. (BSTC) for an estimated equity value of $658.0 million.

ENDP is currently trading at $5.35, up $0.37 or 7.43%, on the Nasdaq.

Endo International will buy BioSpecifics Technologies for an estimated equity value of around $658.0 million or $88.50 per share in cash.

The transaction was unanimously approved by both BioSpecifics' and Endo's Boards of Directors and is anticipated to close during the fourth quarter of 2020.

"BioSpecifics Technologies Corp. pioneered the development of collagenase-based therapies, which has resulted in a robust injectable collagenase (CCH) portfolio, consisting of XIAFLEX to treat the vast number of diseases and medical conditions caused by the excess accumulation of collagen and Qwo for the treatment of cellulite," said CEO Joseph Truitt.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Latest Markets Videos


Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Learn More